The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Nature medicine · 2024 · 168 citations · Mohamed Abdelbaki
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 90 citations · Lauren Weintraub
Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2.
JAMA network open · 2021 · 306 citations · Ilana Harwayne-Gidansky
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.
The New England journal of medicine · 2021 · 288 citations · Mohamed Abdelbaki
Neonatal Hypoxic-Ischemic Encephalopathy and Hypothermia Treatment.
Obstetrics and gynecology · 2024 · 40 citations · Sanghamitra Sinha
Race, Ethnicity, Language, and the Treatment of Low-Risk Febrile Infants.
JAMA pediatrics · 2024 · 30 citations · Sonali Bhalodkar
Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative.
JAMA pediatrics · 2022 · 72 citations · Sachin Tadphale
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
Neuro-oncology · 2022 · 112 citations · Mohamed Abdelbaki